赛托生物2024年亏损8877万元下降294.6%

财中社2025-04-28

4月28日，赛托生物(300583)公布2024年年报，公司营业收入为9.71亿元，同比下降24.2%；归母净利润亏损8877万元，同比下降294.6%；扣非归母净利润亏损1.03亿元，同比下降521.4%；经营现金流净额为1.94亿元，同比增长309.4%；EPS(全面摊薄)为-0.4679元。其中第四季度，公司营业收入为2.06亿元，同比下降42.3%；归母净利润自去年同期亏损1555万元变为...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2530288226?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-28 20:50","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2530288226","market":"other","top_or_hot":-1,"title":"赛托生物2024年亏损8877万元  下降294.6%","media":"财中社","content":"<div>\n<p>4月28日，赛托生物(300583)公布2024年年报，公司营业收入为9.71亿元，同比下降24.2%；归母净利润亏损8877万元，同比下降294.6%；扣非归母净利润亏损1.03亿元，同比下降521.4%；经营现金流净额为1.94亿元，同比增长309.4%；EPS(全面摊薄)为-0.4679元。其中第四季度，公司营业收入为2.06亿元，同比下降42.3%；归母净利润自去年同期亏损1555万元变为...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/zqgd/2025-04-28/doc-ineutqhn8837194.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>赛托生物2024年亏损8877万元  下降294.6%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n赛托生物2024年亏损8877万元  下降294.6%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-28 20:50 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/zqgd/2025-04-28/doc-ineutqhn8837194.shtml><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>4月28日，赛托生物(300583)公布2024年年报，公司营业收入为9.71亿元，同比下降24.2%；归母净利润亏损8877万元，同比下降294.6%；扣非归母净利润亏损1.03亿元，同比下降521.4%；经营现金流净额为1.94亿元，同比增长309.4%；EPS(全面摊薄)为-0.4679元。其中第四季度，公司营业收入为2.06亿元，同比下降42.3%；归母净利润自去年同期亏损1555万元变为...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/zqgd/2025-04-28/doc-ineutqhn8837194.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"https://finance.sina.com.cn/stock/zqgd/2025-04-28/doc-ineutqhn8837194.shtml","article_id":"2530288226","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2530288226","pubTimestamp":1745844600,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"4月28日，赛托生物公布2024年年报，公司营业收入为9.71亿元，同比下降24.2%；归母净利润亏损8877万元，同比下降294.6%；扣非归母净利润亏损1.03亿元，同比下降521.4%；经营现金流净额为1.94亿元，同比增长309.4%；EPS为-0.4679元。其中第四季度，公司营业收入为2.06亿元，同比下降42.3%；归母净利润自去年同期亏损1555万元变为亏损1.03亿元，亏损额进一步扩大；扣非归母净利润自去年同期亏损1316万元变为亏损1.09亿元，亏损额进一步扩大；EPS为-0.5455元。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300583":"赛托生物","BK0239":"医药制造"},"translate_title":"Saito Bio will lose 88.77 million yuan in 2024, a decrease of 294.6%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300583":1},"content_text":"4月28日，赛托生物(300583)公布2024年年报，公司营业收入为9.71亿元，同比下降24.2%；归母净利润亏损8877万元，同比下降294.6%；扣非归母净利润亏损1.03亿元，同比下降521.4%；经营现金流净额为1.94亿元，同比增长309.4%；EPS(全面摊薄)为-0.4679元。其中第四季度，公司营业收入为2.06亿元，同比下降42.3%；归母净利润自去年同期亏损1555万元变为亏损1.03亿元，亏损额进一步扩大；扣非归母净利润自去年同期亏损1316万元变为亏损1.09亿元，亏损额进一步扩大；EPS为-0.5455元。截至四季度末，公司总资产30.26亿元，较上年度末下降6.6%；归母净资产为18.39亿元，较上年度末下降8.6%。需要注意的是，上年财务数据因为会计准则变化发生了重述，上文计算基于重述前的数据。公司在2024年年度报告中提到，业绩出现大幅波动，主要原因是产品价格下行导致销售收入和毛利率减少，影响了净利润。此外，因甾体类中间体产品市场价格下行，公司计提了存货减值，进一步影响了净利润。尽管面临这些挑战，公司在产品销量和客户数量上实现了双提升，经营活动现金流稳健，期间费用略有减少。在未来的发展中，公司计划通过提升技术和优化生产流程，降低产品成本，增强市场竞争力，确保稳健可持续的发展目标。主营业务和核心竞争力未发生重大不利变化，整体经营情况与行业趋势一致。公司将继续关注行业变化，确保适应市场需求和政策调整。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2530288226","isCrawlerRequest":true}

赛托生物2024年亏损8877万元 下降294.6%

精彩评论

赛托生物2024年亏损8877万元下降294.6%